What changed in this filing

/stocks — the workspaceLOADING

Item 5. Market for Registrant’s Common Equity

2025-03-31 compared with 2024-03-27 · 21 added, 28 removed, 28 unchanged (64% of the section changed)

5 - MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Our common stock

is listed on the NYSE American LLC Exchange, where it trades under the symbol “DSS”.

common stock is listed on the NYSE American LLC Exchange, where it trades under the symbol “DSS”.

of March 24, 2025, we had 311 record holders of our common stock.

This number does not include the number

of persons whose shares are in nominee or in “street name” accounts through brokers.

We did not pay

dividends during 2022.

This number does not include the number of persons whose shares

are in nominee or in “street name” accounts through brokers.

did not pay dividends during 2024.

In 2023, we did not pay cash dividends.

In April 2023, DSS distributed to its shareholders two (2) shares of

its beneficially owned common stock of Sharing Services Global Corporation (OTC:

In April 2023, DSS distributed to its shareholders two (2)

shares of its beneficially owned common stock of Sharing Services Global Corporation (OTC:

SHRG) for each share of DSS common stock owned.

August of 2023, the Company issued four (4) shares of Impact BioMedical, Inc., formerly a wholly-owned subsidiary of the Company, to

its shareholders of record on July 10, 2023.

The payment of dividends

on our common stock is subject to the discretion of our board of directors and will depend on our operations, financial position, financial

requirements, general business conditions, restrictions imposed by financing arrangements, if any, legal restrictions on the payment

of dividends and other factors that our board of directors deems relevant.

In August of 2023, the Company issued four (4) shares of Impact BioMedical, Inc., formerly a wholly-owned subsidiary of the Company,

to its shareholders of record on July 10, 2023.

payment of dividends on our common stock is subject to the discretion of our board of directors and will depend on our operations, financial

position, financial requirements, general business conditions, restrictions imposed by financing arrangements, if any, legal restrictions

on the payment of dividends and other factors that our board of directors deems relevant.

Authorized for Issuance Under Equity Compensation Plans

As of December 31,

2023, securities issued and securities available for future issuance under both our 2013 and 2020 Employee, Director and Consultant Equity

Incentive Plan (the “Plans”) is as follows:

of December 31, 2024, securities issued and securities available for future issuance under both our 2013 and 2020 Employee, Director

and Consultant Equity Incentive Plan (the “Plans”) is as follows:

Restricted stock to be issued upon vesting

13 unchanged sentences

Issuances of Unregistered Securities

Information regarding

any equity securities we have sold during the period covered by this Report that were not registered under the Securities Act of 1933,

as amended, and was not included in a quarterly report on Form 10-Q or in a current report on Form 8-K, is set forth below.

transaction was exempt from the registration requirements of the Securities Act by virtue of Section 4(a)(2) of the Securities Act or

Rule 506 of Regulation D promulgated by the SEC, unless otherwise noted.

regarding any equity securities we have sold during the period covered by this Report that were not registered under the Securities Act

of 1933, as amended, and was not included in a quarterly report on Form 10-Q or in a current report on Form 8-K, is set forth below.

Each such transaction was exempt from the registration requirements of the Securities Act by virtue of Section 4(a)(2) of the Securities

Act or Rule 506 of Regulation D promulgated by the SEC, unless otherwise noted.

Unless stated otherwise:

(i) the securities were offered and

sold only to accredited investors;

(i) the securities were offered

and sold only to accredited investors;

(ii) there was no general solicitation or general advertising related to the offerings;

of the persons who received these unregistered securities had knowledge and experience in financial and business matters which allowed

each of the persons who received these unregistered securities had knowledge and experience in financial and business matters which allowed

them to evaluate the merits and risk of the receipt of these securities, and that they were knowledgeable about our operations and financial

3 unchanged sentences

Repurchased by the Registrant

We did not purchase

or repurchase any of our securities in the fiscal year ended December 31, 2023.

did not purchase or repurchase any of our securities in the fiscal year ended December 31, 2024.

6 - SELECTED FINANCIAL DATA

Not applicable.

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 5. Market for Registrant’s Common Equity